Validation pour Ingenuity287

vers la météo de la validation par utilisateur

Ingenuity287

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 0 - PMID ?

In pancreatic islets from male Zucker diabetic fatty SP , oral administration of NODE ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of SP NODE mRNA .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 1

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 2

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 3

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 4

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 5

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 6

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 7

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 8

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 9

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 10

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 11

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 12

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 13

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 14

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 15

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 16

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 17

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 18

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 19

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 20

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 21

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 22

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 23

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 24

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 25

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 26

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 27

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 28

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 29

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 30

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 31

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 32

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 33

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 34

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 35

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 36

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 37

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 38

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 39

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 40

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 41

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 42

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 43

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 44

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 45

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 46

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 47

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 48

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 49

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 50

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 51

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 52

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 53

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 54

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 55

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 56

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 57

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 58

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 59

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 60

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 61

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 62

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 63

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |                                      |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 |                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 64

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 65

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 66

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 67

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 68

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 69

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 70

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 71

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 72

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 73

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 74

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 75

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 76

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 77

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 78

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 79

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 80

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 81

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 82

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 83

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  +------------COMP:N-N(from)------------+                                                                                                              |                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,__SP__)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 84

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 85

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 86

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 87

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 88

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 89

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 90

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 91

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 92

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 93

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 94

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +MOD_ATT:N-ADJ+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 95

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +------------------------------------------------COMP:V-N(from)------------------------------------------------+                                         
                  |          +--------MOD_ATT:N-N--------+                 +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |          |     +-----MOD_ATT:N-N-----+                 |                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |          |     |       +-MOD_ATT:N-N-+                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          |     |       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-N (__SP__,Zucker)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 96

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 97

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 98

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 99

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 100

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 101

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 102

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 103

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 104

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 105

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 106

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 107

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 108

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 109

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 110

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 111

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 112

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 113

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 114

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 115

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 116

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 117

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 118

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 119

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 120

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 121

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 122

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 123

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 124

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 125

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 126

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 127

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 128

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 129

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 130

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 131

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 132

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 133

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 134

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 135

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 136

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 137

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +---------MOD_ATT:N-ADJ---------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 138

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 139

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 140

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 141

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 142

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 143

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +MOD_ATT:N-ADJ+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-ADJ (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 144

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 145

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 146

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 147

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 148

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 149

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 150

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 151

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 152

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 153

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 154

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 155

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 156

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 157

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 158

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 159

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 160

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 161

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 162

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 163

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 164

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 165

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 166

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 167

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 168

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 169

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 170

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 171

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 172

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 173

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 174

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 175

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 176

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 177

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 178

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 179

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 180

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 181

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 182

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 183

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 184

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 185

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 186

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 187

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 188

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 189

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 190

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 191

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-ADJ (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 192

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 193

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 194

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 195

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 196

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 197

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+              +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 198

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 199

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 200

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 201

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 202

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 203

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 204

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 205

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                +--------------------------APPOS-------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 206

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 207

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                 +---------------------------------APPOS---------------------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 208

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 209

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 210

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 211

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                                        +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 212

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 213

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 214

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 215

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 216

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 217

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                                       +------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+                       +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 218

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 219

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                                      |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 220

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 221

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 222

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 223

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |                                         
                  |                |                     |                                         |                      +------------COMP:N-N(of)-----------+         |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 224

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 225

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 226

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 227

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                        +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                        |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 228

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 229

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 230

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 231

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 232

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 233

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |       +----------MOD_ATT:N-N----------+------------------------------------------SUBJ:V-N------------------------------------------+                                         
                  |                |       |      +------MOD_ATT:N-ADJ-----+                       +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       |      |      +--MOD_ATT:N-ADJ--+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      |      |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (administration,diabetic)
MOD_ATT:N-ADJ (administration,fatty)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 234

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 235

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                                      +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                                      |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  +-COMP:N-N(from)-+       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
COMP:N-N(from) (islet,Zucker)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 236

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 237

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 238

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 239

                  +---------------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------------+                                         
                  |                +-----------------------------------------------------------COMP:V-N(from)-----------------------------------------------------------+                                         
                  |                |                     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                         
                  |                |                     |                                         +--------------------OBJ:V-N--------------------+                    |          +-------COMP:N-N(of)-------+   
                  |                |       +-MOD_ATT:N-N-+------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(o+         |          |           +-MOD_ATT:N-ADJ+   
         +MOD_ATT:+          +MOD_A+       |      +MOD_AT+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+      +MOD+         +--OBJ:V-N-+           |       +MOD_AT+   
         |        |          |     |       |      |      |       |         |              |        |       |       |      |               |        |      |   |         |          |           |       |      |   
 In pancreatic islets from male Zucker diabetic fatty __SP__ , oral administration of __NODE__ ( with a dosage of 150 mg/kg/day and a treatment period of 8 weeks ) decreases expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (islet,pancreatic)
MOD_ATT:N-N (Zucker,male)
MOD_ATT:N-N (__SP__,diabetic)
MOD_ATT:N-ADJ (__SP__,fatty)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
MOD_ATT:N-ADJ (week,8)
COMP:V-N(In) (decrease,islet)
COMP:V-N(from) (decrease,Zucker)
SUBJ:V-N (decrease,__SP__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)